Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer
- 1 November 1990
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 17 (1) , 45-50
- https://doi.org/10.1007/bf01812683
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacokinetics and metabolism of medroxyprogesterone acetate in patients with advanced breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1988
- THE INFLUENCE OF PROGESTINS ON RECEPTOR LEVELS IN BREAST-CANCER METASTASIS1987
- ENDOCRINE THERAPY FOR ADVANCED-CARCINOMA OF THE BREAST - RELATIONSHIP BETWEEN THE EFFECT OF TAMOXIFEN UPON CONCENTRATIONS OF PROGESTERONE-RECEPTOR AND SUBSEQUENT RESPONSE TO TREATMENT1987
- High-dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer.1986
- EFFECTS OF TAMOXIFEN ON ESTROGEN AND PROGESTERONE RECEPTORS IN HUMAN-BREAST CANCER1981
- Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer InstitutePublished by Elsevier ,1980
- Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer.1980
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978
- CHARACTERIZATION AND ASSAY OF PROGESTERONE RECEPTOR IN HUMAN MAMMARY-CARCINOMA1977
- Assessment of response to therapy in advanced breast cancerPublished by Elsevier ,1977